Analysts Diverge On Celgene's Deal With Juno Therapeutics By: Benzinga via Benzinga June 30, 2015 at 11:37 AM EDT Whether Celgene Corporation (NASDAQ: CELG) went too far in its $1 billion development deal with Juno Therapeutics Inc (NASDAQ: JUNO) ... Read More >> Related Stocks: Bank of Montreal Celgene Corp JMP Group Inc